Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4226700
Max Phase: Preclinical
Molecular Formula: C29H29N7O8
Molecular Weight: 603.59
Molecule Type: Small molecule
Associated Items:
ID: ALA4226700
Max Phase: Preclinical
Molecular Formula: C29H29N7O8
Molecular Weight: 603.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)[C@H](CC(=O)O)NC(=O)OCC2c3ccccc3-c3ccccc32)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C29H29N7O8/c30-25-22-26(33-12-32-25)36(13-34-22)28-24(40)23(39)20(44-28)10-31-27(41)19(9-21(37)38)35-29(42)43-11-18-16-7-3-1-5-14(16)15-6-2-4-8-17(15)18/h1-8,12-13,18-20,23-24,28,39-40H,9-11H2,(H,31,41)(H,35,42)(H,37,38)(H2,30,32,33)/t19-,20+,23+,24+,28+/m0/s1
Standard InChI Key: ZSCHHFLDGKEBNA-SFCVBKHESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 603.59 | Molecular Weight (Monoisotopic): 603.2078 | AlogP: 0.53 | #Rotatable Bonds: 9 |
Polar Surface Area: 224.04 | Molecular Species: ACID | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.83 | CX Basic pKa: 4.96 | CX LogP: -0.39 | CX LogD: -2.98 |
Aromatic Rings: 4 | Heavy Atoms: 44 | QED Weighted: 0.15 | Np Likeness Score: 0.23 |
1. Zhang Y, Jumppanen M, Maksimainen MM, Auno S, Awol Z, Ghemtio L, Venkannagari H, Lehtiö L, Yli-Kauhaluoma J, Xhaard H, Boije Af Gennäs G.. (2018) Adenosine analogs bearing phosphate isosteres as human MDO1 ligands., 26 (8): [PMID:29501416] [10.1016/j.bmc.2018.02.006] |
Source(1):